Stay updated on Extension of AK002 in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now presents the completed Phase 2 AK002 extension study record, including its locations, eligibility criteria, treatment plan, outcome measures, and study documents.SummaryDifference52%

- Check16 days agoChange DetectedThe ClinicalTrials.gov study record remains unavailable behind a 403 Forbidden error. The footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision indicator changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision updated to v3.7.0. A substantial block of historical study document metadata and related labels was removed, resulting in a leaner Study Details page.SummaryDifference17%

Stay in the know with updates to Extension of AK002 in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension of AK002 in Eosinophilic Gastritis Clinical Trial page.